Literature DB >> 20562457

Molecular characterisation of congenital myasthenic syndromes in Southern Brazil.

V Mihaylova1, R H Scola, B Gervini, P J Lorenzoni, C K Kay, L C Werneck, R Stucka, V Guergueltcheva, M von der Hagen, A Huebner, A Abicht, J S Müller, H Lochmüller.   

Abstract

OBJECTIVE: To perform genetic testing of patients with congenital myasthenic syndromes (CMS) from the Southern Brazilian state of Parana. PATIENTS AND METHODS: Twenty-five CMS patients from 18 independent families were included in the study. Known CMS genes were sequenced and restriction digest for the mutation RAPSN p.N88K was performed in all patients.
RESULTS: We identified recessive mutations of CHRNE in ten families, mutations in DOK7 in three families and mutations in COLQ, CHRNA1 and CHRNB1 in one family each. The mutation CHRNE c.70insG was found in six families. We have repeatedly identified this mutation in patients from Spain and Portugal and haplotype studies indicate that CHRNE c.70insG derives from a common ancestor.
CONCLUSIONS: Recessive mutations in CHRNE are the major cause of CMS in Southern Brazil with a common mutation introduced by Hispanic settlers. The second most common cause is mutations in DOK7. The minimum prevalence of CMS in Parana is 0.18/100 000.

Entities:  

Mesh:

Year:  2010        PMID: 20562457     DOI: 10.1136/jnnp.2009.177816

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles.

Authors:  Yanyan Ma; Ting Xiong; Guohua Lei; Jiaqi Ding; Rui Yang; Zunbo Li; Jun Guo; Dingguo Shen
Journal:  Neurol Sci       Date:  2021-01-13       Impact factor: 3.307

2.  Congenital myasthenic syndrome in Israel: Genetic and clinical characterization.

Authors:  Sharon Aharoni; Menachem Sadeh; Yehuda Shapira; Simon Edvardson; Muhannad Daana; Talia Dor-Wollman; Aviva Mimouni-Bloch; Ayelet Halevy; Rony Cohen; Liora Sagie; Zohar Argov; Malcolm Rabie; Ronen Spiegel; Ilana Chervinsky; Naama Orenstein; Andrew G Engel; Yoram Nevo
Journal:  Neuromuscul Disord       Date:  2016-11-24       Impact factor: 4.296

3.  Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.

Authors:  Kun Huang; Hui-Qian Duan; Qiu-Xiang Li; Yue-Bei Luo; Fang-Fang Bi; Huan Yang
Journal:  J Cell Mol Med       Date:  2022-06-06       Impact factor: 5.295

4.  Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings.

Authors:  Marta Gómez-García de la Banda; Emmanuel Simental-Aldaba; Nagia Fahmy; Damien Sternberg; Patricia Blondy; Susana Quijano-Roy; Edoardo Malfatti
Journal:  Front Neurol       Date:  2022-06-02       Impact factor: 4.086

5.  A common CHRNE mutation in Brazilian patients with congenital myasthenic syndrome.

Authors:  Eduardo de Paula Estephan; Cláudia Ferreira da Rosa Sobreira; André Clériston José Dos Santos; Pedro José Tomaselli; Wilson Marques; Roberta Paiva Magalhães Ortega; Marcela Câmara Machado Costa; André Macedo Serafim da Silva; Rodrigo Holanda Mendonça; Vitor Marques Caldas; Antonio Alberto Zambon; Osório Abath Neto; Paulo Eurípedes Marchiori; Carlos Otto Heise; Umbertina Conti Reed; Yoshiteru Azuma; Ana Töpf; Hanns Lochmüller; Edmar Zanoteli
Journal:  J Neurol       Date:  2018-01-30       Impact factor: 4.849

6.  Mitochondrial disorder mimicking rheumatoid disease.

Authors:  Josef Finsterer; Madleine Melichart-Kotig; Adelheid Woehrer
Journal:  Z Rheumatol       Date:  2019-11       Impact factor: 1.372

7.  A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome.

Authors:  Amina Chaouch; Juliane S Müller; Velina Guergueltcheva; Marina Dusl; Ulrike Schara; Vidosava Rakocević-Stojanović; Christopher Lindberg; Rosana H Scola; Lineu C Werneck; Jaume Colomer; Andres Nascimento; Juan J Vilchez; Nuria Muelas; Zohar Argov; Angela Abicht; Hanns Lochmüller
Journal:  J Neurol       Date:  2011-08-07       Impact factor: 4.849

8.  Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia.

Authors:  Li Di; Hai Chen; Yan Lu; Duygu Selcen; Andrew G Engel; Yuwei Da; Xin-Ming Shen
Journal:  Neurology       Date:  2020-09-09       Impact factor: 9.910

9.  Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in CHRNE gene.

Authors:  Anna Ardissone; Isabella Moroni; Pia Bernasconi; Raffaella Brugnoni
Journal:  Acta Myol       Date:  2017-03

10.  Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile.

Authors:  Jorge A Bevilacqua; Marian Lara; Jorge Díaz; Mario Campero; Jessica Vázquez; Ricardo A Maselli
Journal:  Eur J Transl Myol       Date:  2017-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.